Neurocrine Biosciences NBIX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's total costs & expenses?
- Neurocrine Biosciences (NBIX) reported total costs & expenses of $621.1M in Q1 2026.
- How has Neurocrine Biosciences's total costs & expenses changed year-over-year?
- Neurocrine Biosciences's total costs & expenses increased by 13.1% year-over-year, from $549M to $621.1M.
- What is the long-term trend for Neurocrine Biosciences's total costs & expenses?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's total costs & expenses has grown at a 21.4% compound annual growth rate (CAGR), from $1.03B to $2.24B.